SCHEMBL6696494

SCHEMBL6696494

CS(=O)(=O)Nc1ccc([C]=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
ALDH1A1 P00352 3/20 0.55
LMNA P02545 3/20 0.55
HPGD P15428 2/20 0.55
KDM4E B2RXH2 1/20 0.55
HTT P42858 1/20 0.55
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
KIF11 P52732 4/20 0.52
PGR P06401 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
NR3C2 P08235 2/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
AR P10275 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12054668 0.83 KEAP1 (0.75) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL478987 0.81 KEAP1 (0.54) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL15904063 0.81 KEAP1 (0.54) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL4959361 0.81 CA1 (0.66) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL3059775 0.79 HPGD (0.60) SMN1; SMN2LMNAHPGDHTTCA1
SCHEMBL10193562 0.79 KEAP1 (0.52) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL9835622 0.78 KEAP1 (0.56) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL3793259 0.78 CA1 (0.42) HPGDCA12CA1CA2CA9
SCHEMBL3099756 0.78 HPGD (0.53) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL31041151 0.77 KIF11 (0.79) KEAP1SMN1; SMN2ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142999-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2004-07-22 US disclosed
EP-0558076-B1 Silver halide photographic material FUJI PHOTO FILM CO LTD (JP) 1999-05-06 EP disclosed
US-5891614-A FORMING HALOGEN COMPOSITION GAP FACES AT TIME OF NUCLEATION TO PRODUCE TABULAR GRAINS FUJI PHOTO FILM CO., LTD. (JP) 1999-04-06 US disclosed
WO-1998037078-A1 SOLID PHASE AND COMBINATORIAL SYNTHESIS OF SUBSTITUTED THIOPHENES AND OF ARRAYS OF SUBSTITUTED THIOPHENES NOVO NORDISK A/S (DK) 1998-08-27 WO disclosed
EP-0528435-B1 Silver halide photographic material FUJI PHOTO FILM CO LTD (JP) 1997-05-21 EP disclosed
US-5582962-A COLLOID LAYERS COMPRISING A DISPERSE DYE PARTICLES KONICA CORPORATION (JP) 1996-12-10 US disclosed
EP-0401709-B1 X-ray photographic material FUJI PHOTO FILM CO LTD (JP) 1995-12-27 EP disclosed
EP-0679935-A2 Silver halide photographic light-sensitive material and the processing method thereof KONICA CORPORATION (JP) 1995-11-02 EP disclosed
US-5340707-A Containing specified pyrazolone dye; storage stability KONICA CORPORATION (JP) 1994-08-23 US disclosed
US-5328818-A Support with color couplers in emulsions in multilayer element FUJI PHOTO FILM CO., LTD. (JP) 1994-07-12 US disclosed
US-5147769-A Image sharpness FUJI PHOTO FILM CO., LTD. (JP) 1992-09-15 US disclosed
EP-0215124-B1 SILVER HALIDE PHOTOGRAPHIC PHOTO-SENSITIVE MATERIAL FUJI PHOTO FILM CO., LTD. (JP) 1991-09-04 EP disclosed
EP-0435561-A2 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1991-07-03 EP disclosed
EP-0434413-A1 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1991-06-26 EP disclosed
EP-0401709-A2 X-ray photographic material FUJI PHOTO FILM CO., LTD. (JP) 1990-12-12 EP disclosed
US-4925782-A Silver halide photographic light-sensitive element containing water soluble dye compounds FUJI PHOTO FILM CO., LTD. (JP) 1990-05-15 US disclosed
US-4879204-A HIGH CONTRAST FUJI PHOTO FILM CO., LTD. (JP) 1989-11-07 US disclosed
US-4764455-A Color image-forming process FUJI PHOTO FILM CO., LTD. (JP) 1988-08-16 US disclosed
EP-0215124-A1 SILVER HALIDE PHOTOGRAPHIC PHOTO-SENSITIVE MATERIAL FUJI PHOTO FILM CO., LTD. (JP) 1987-03-25 EP disclosed
US-3931142-A Heterocyclic containing disazo compounds CIBA-GEIGY AG (CH) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142999-A1 Novel compounds and compositions as cathepsin inhibitors CTSS, CTSB, CTSE KEAP1 1957/4885SMN1; SMN2 3350/4885ALDH1A1 4046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.